DK0948319T3 - Indkapslede antistofdannende celler - Google Patents

Indkapslede antistofdannende celler

Info

Publication number: DK0948319T3
Authority: DK; Denmark
Prior art keywords: forming cells; encapsulated antibody; antibody; encapsulated; capsules
Prior art date: 1996-12-23

Application number

DK97954822T

Other languages

English (en)

Inventor

Marc Piechaczyk

Mireia Pelegrin

Mariana Marin

Robert Saller

Brian Salmons

Original Assignee

Bavarian Nordic As

Centre Nat Rech Scient

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-23

Filing date

1997-12-18

Publication date

2004-02-09

1997-12-18 Application filed by Bavarian Nordic As, Centre Nat Rech Scient filed Critical Bavarian Nordic As

2004-02-09 Application granted granted Critical

2004-02-09 Publication of DK0948319T3 publication Critical patent/DK0948319T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK97954822T 1996-12-23 1997-12-18 Indkapslede antistofdannende celler DK0948319T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK149796		1996-12-23
PCT/EP1997/007120 WO1998027966A2 (en)	1996-12-23	1997-12-18	Encapsulated cells producing antibodies

Publications (1)

Publication Number	Publication Date
DK0948319T3 true DK0948319T3 (da)	2004-02-09

Family

ID=8105461

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97954822T DK0948319T3 (da)	1996-12-23	1997-12-18	Indkapslede antistofdannende celler

Country Status (11)

Country	Link
US (1)	US6426088B1 (da)
EP (1)	EP0948319B1 (da)
JP (2)	JP4727768B2 (da)
AT (1)	ATE252374T1 (da)
AU (1)	AU6205998A (da)
DE (1)	DE69725754T2 (da)
DK (1)	DK0948319T3 (da)
ES (1)	ES2208973T3 (da)
PT (1)	PT948319E (da)
SI (1)	SI0948319T1 (da)
WO (1)	WO1998027966A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020168339A1 (en) *	1997-01-20	2002-11-14	Marc Piechaczyk	Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
US6261281B1 (en)	1997-04-03	2001-07-17	Electrofect As	Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
JP2004504835A (ja) *	2000-07-29	2004-02-19	スミス　アンド　ネフュー　ピーエルシー	組織インプラント
US20040014698A1 (en) *	2002-07-18	2004-01-22	Gonzalo Hortelano	Oral administration of therapeutic agent coupled to transporting agent
US20040014704A1 (en) *	2002-07-18	2004-01-22	Gonzalo Hortelano	Oral administration of therapeutic agent coupled to transporting agent induces tolerance
US20040016013A1 (en) *	2002-07-18	2004-01-22	Gonzalo Hortelano	Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent
US20040220085A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Compositions for nucleic acid delivery
US20040219099A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Method for the treatment of tumors
US20050208032A1 (en) *	2004-01-16	2005-09-22	Gonzalo Hortelano	Oral administration of therapeutic agent coupled to transporting agent
DE102005011367B4 (de) *	2005-03-11	2010-12-09	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Verfahren zur Herstellung von Cellulosesulfat mit verbesserten Eigenschaften
NZ613473A (en)	2011-01-25	2015-05-29	Austrianova Singapore Pte Ltd	Protection of microbial cells from acidic degradation
GB201408233D0 (en)	2014-05-09	2014-06-25	Austrianova Singapore Pte Ltd	Use of polyanionic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6025929A (ja) *	1983-07-20	1985-02-08	ザ・スト−ル・リサ−チ・アンド・デイベロツプメント・コ−ポレ−シヨン	カプセル化細胞、その製造方法および用途
EP0280155B1 (de) *	1987-02-25	1992-05-20	Hoechst Aktiengesellschaft	Mikroenkapsulierung von biologisch aktivem Material
US5427935A (en)	1987-07-24	1995-06-27	The Regents Of The University Of Michigan	Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
US5116747A (en) *	1989-08-11	1992-05-26	University Of Waterloo	Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate
US5686113A (en) *	1995-03-21	1997-11-11	Temple University Of The Commonwealth System Of Higher Education	Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
US5997900A (en) *	1996-04-17	1999-12-07	Wang; Taylor G.	Encapsulation system for the immunoisolation of living cells

1997
- 1997-12-18 EP EP97954822A patent/EP0948319B1/en not_active Expired - Lifetime
- 1997-12-18 ES ES97954822T patent/ES2208973T3/es not_active Expired - Lifetime
- 1997-12-18 PT PT97954822T patent/PT948319E/pt unknown
- 1997-12-18 SI SI9730601T patent/SI0948319T1/xx unknown
- 1997-12-18 AT AT97954822T patent/ATE252374T1/de active
- 1997-12-18 DE DE69725754T patent/DE69725754T2/de not_active Expired - Lifetime
- 1997-12-18 JP JP52835398A patent/JP4727768B2/ja not_active Expired - Fee Related
- 1997-12-18 WO PCT/EP1997/007120 patent/WO1998027966A2/en not_active Ceased
- 1997-12-18 AU AU62059/98A patent/AU6205998A/en not_active Abandoned
- 1997-12-18 US US09/331,447 patent/US6426088B1/en not_active Expired - Lifetime
- 1997-12-18 DK DK97954822T patent/DK0948319T3/da active
2008
- 2008-10-06 JP JP2008259300A patent/JP2009013182A/ja active Pending

Also Published As

Publication number	Publication date
DE69725754D1 (de)	2003-11-27
EP0948319A2 (en)	1999-10-13
US6426088B1 (en)	2002-07-30
ES2208973T3 (es)	2004-06-16
WO1998027966A2 (en)	1998-07-02
AU6205998A (en)	1998-07-17
SI0948319T1 (en)	2004-04-30
ATE252374T1 (de)	2003-11-15
JP4727768B2 (ja)	2011-07-20
JP2009013182A (ja)	2009-01-22
EP0948319B1 (en)	2003-10-22
PT948319E (pt)	2004-02-27
JP2001507344A (ja)	2001-06-05
WO1998027966A3 (en)	1998-11-12
DE69725754T2 (de)	2004-08-19

Publication	Publication Date	Title
NO962088D0 (no)	1996-05-22	Preparat for in vivo-produksjon av terapeutiske produkter
HUP9802212A2 (hu)	1999-01-28	Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
HUP0002831A3 (en)	2005-11-28	Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
WO1997019111A3 (es)	1998-02-12	Anticuerpos monoclonales anti-cd6 y sus utilizaciones
TR199903331T2 (xx)	2000-06-21	Farnesil protein transferas engelleyicileri.
AP9801392A0 (en)	1998-12-31	Concentrated antibody preparation.
WO1995016038A3 (en)	1995-07-06	Humanized antibodies and uses thereof
EP0783299A4 (en)	1999-06-30	COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
DK0948319T3 (da)	2004-02-09	Indkapslede antistofdannende celler
AU6649996A (en)	1997-02-26	Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
WO1997008318A3 (en)	1997-04-17	Compounds and methods for treatment and diagnosis of prostate cancer
ATE396205T1 (de)	2008-06-15	Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
ATE234636T1 (de)	2003-04-15	Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
DK403384A (da)	1984-08-23	Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
GR3020355T3 (en)	1996-09-30	Aminosulfonyl urea acat inhibitors
TR200401775T4 (tr)	2004-09-21	3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
ZA983239B (en)	1998-10-29	Stable active human ob protein compositions and methods
EP0821969A3 (en)	2000-12-13	Medicinal Composition comprising TCF-II
PL330597A1 (en)	1999-05-24	Transcutaneous systems containing two active ingredients in separate compartments, method of obtaining them and their application as therapeutic agents
EA200000909A1 (ru)	2001-06-25	ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
LV12149A (lv)	1998-10-20	5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
TR199802496T2 (xx)	1999-02-22	Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
TR199800705T2 (da)	1998-09-21
SI1027375T1 (sl)	2007-02-28	Anti-idiotipska monoklonska protitelesa, njihova uporaba v aktivni imunoterapiji malignih tumorjev in sestavki, ki jih vsebujejo